Samuel R. Fernandes

Santa Maria, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

Superior Effectiveness of Upadacitinib Over Tofacitinib and Ustekinumab in Bio-Exposed Ulcerative Colitis: The TRIDENT-UC Study.

Superior Effectiveness of Upadacitinib Over Tofacitinib and Ustekinumab in Bio-Exposed Ulcerative Colitis: The TRIDENT-UC Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 17, 2026

Distinct hepcidin patterns in Crohn's disease and ulcerative colitis: links to iron homeostasis and inflammatory activity.

Distinct hepcidin patterns in Crohn's disease and ulcerative colitis: links to iron homeostasis and inflammatory activity.

Journal: Journal of Crohn's & colitis

Published: March 17, 2026

External validation of a prediction score for identifying a mild course of Crohn's disease.

External validation of a prediction score for identifying a mild course of Crohn's disease.

Journal: European journal of gastroenterology & hepatology

Published: March 09, 2026

Early Intervention Prevents Disease Progression in Ulcerative Colitis - A Multicenter Retrospective Study.

Early Intervention Prevents Disease Progression in Ulcerative Colitis - A Multicenter Retrospective Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 01, 2025

Development of a Cost-Effective Multiparametric Probe for Continuous Real-Time Monitoring of Aquatic Environments.

Development of a Cost-Effective Multiparametric Probe for Continuous Real-Time Monitoring of Aquatic Environments.

Journal: Sensors (Basel, Switzerland)

Published: October 10, 2025

Soluble transferrin receptor as a reliable inflammation-independent marker of iron deficiency in Crohn's disease and ulcerative colitis.

Soluble transferrin receptor as a reliable inflammation-independent marker of iron deficiency in Crohn's disease and ulcerative colitis.

Journal: Inflammatory bowel diseases

Published: September 26, 2025

Transmural improvement may be an acceptable target in patients with Crohns disease.

Transmural improvement may be an acceptable target in patients with Crohns disease.

Journal: Inflammatory bowel diseases

Published: September 15, 2025

Longitudinal profiles of fecal calprotectin and C-reactive protein in relation to outcomes in Crohn's disease patients on infliximab.

Longitudinal profiles of fecal calprotectin and C-reactive protein in relation to outcomes in Crohn's disease patients on infliximab.

Journal: Journal of Crohn's & colitis

Published: August 12, 2025

Outcomes of acute severe ulcerative colitis at initial presentation.

Outcomes of acute severe ulcerative colitis at initial presentation.

Journal: European journal of gastroenterology & hepatology

Published: June 18, 2025

Fecal calprotectin-guided treatment escalation strategy enhances disease clearance in ulcerative colitis.

Fecal calprotectin-guided treatment escalation strategy enhances disease clearance in ulcerative colitis.

Journal: European journal of gastroenterology & hepatology

Published: January 22, 2025

Type 2 inflammation: a Portuguese consensus using Web-Delphi and decision conferencing (INFLAT2-PT).

Type 2 inflammation: a Portuguese consensus using Web-Delphi and decision conferencing (INFLAT2-PT).

Journal: Expert review of clinical immunology

Published: January 03, 2025

Early Top-Down Treatment With Biologics Improves the Rates of Transmural Remission in Crohn's Disease-A Risk-Adjusted Propensity Score Matched Analysis.

Early Top-Down Treatment With Biologics Improves the Rates of Transmural Remission in Crohn's Disease-A Risk-Adjusted Propensity Score Matched Analysis.

Journal: Inflammatory bowel diseases

Published: December 20, 2024

Showing 1-12 of 100

Last Updated: 09/26/2026